Related Experiment Videos
[Carcinoma in situ of the testis in infertile men. Experience in a medically assisted reproduction program]
B Zorn1, I Virant-Klun, J Sinkovec
1Clinique Gynécologique Universitaire, Service d'Aide Médicale à la Reproduction, Ljubljana, Slovénie.
Contraception, Fertilite, Sexualite (1992)
|March 11, 1999
Abstract:
Three cases of carcinoma in situ were found by testicular biopsy among a group of 85 infertile men, most with diagnosed azoospermia. It remains difficult and unclear how to manage such patients to achieve offspring and to assure the adequate oncological therapy.
Insights
Carcinoma in situ was detected in three infertile men with azoospermia via testicular biopsy. Management remains challenging for both fertility and cancer treatment in these cases.
Area of Science:
- Reproductive medicine
- Urologic oncology
- Andrology
Context:
- Testicular biopsy is a diagnostic tool in male infertility evaluations.
- Azoospermia is a common cause of male infertility.
- Carcinoma in situ (CIS) is a pre-invasive form of testicular cancer.
Purpose:
- To report the incidence of testicular carcinoma in situ (CIS) in infertile men with azoospermia.
- To highlight the diagnostic and management challenges posed by CIS in this patient population.
Summary:
- Three cases of testicular carcinoma in situ (CIS) were identified through testicular biopsy in 85 infertile men, predominantly those with azoospermia.
- These findings underscore the importance of considering CIS in the differential diagnosis of male infertility, particularly in cases of azoospermia.
Impact:
- This study contributes to understanding the prevalence of CIS in infertile men.
- It emphasizes the need for clear guidelines on managing CIS in infertile patients to balance fertility preservation and oncological outcomes.